Complete transverse atypical femoral fracture, right leg
ICD-10 M84.754 is a billable code used to indicate a diagnosis of complete transverse atypical femoral fracture, right leg.
A complete transverse atypical femoral fracture is a specific type of fracture that occurs in the femur, typically associated with low-energy trauma or spontaneously in patients with underlying bone density disorders, particularly osteoporosis. This fracture is characterized by a horizontal break across the femur, which can lead to significant morbidity if not diagnosed and treated promptly. Atypical femoral fractures are often linked to long-term bisphosphonate therapy, which is used to treat osteoporosis. Patients may present with thigh pain or discomfort prior to the fracture, and imaging studies such as X-rays or MRI are essential for diagnosis. Treatment usually involves surgical intervention, such as intramedullary nailing, to stabilize the fracture and promote healing. The right leg designation is crucial for accurate coding and treatment planning, as it specifies the affected limb. Understanding the underlying bone metabolism and density disorders is vital for managing these fractures effectively, as they may indicate a need for reevaluation of osteoporosis management strategies.
Detailed notes on fracture type, treatment plan, and follow-up care.
Patients presenting with thigh pain, history of osteoporosis, or recent falls.
Ensure accurate documentation of fracture characteristics and any surgical interventions performed.
Assessment of bone density, medication history, and management of osteoporosis.
Patients with osteoporosis on bisphosphonates presenting with atypical fractures.
Documenting the patient's overall bone health and any changes in treatment plans.
Used in conjunction with fracture management if joint involvement is suspected.
Document the reason for aspiration and findings.
Orthopedic specialists should ensure clarity in documentation regarding joint status.
Accurate coding of M84.754 is crucial for appropriate treatment planning, reimbursement, and tracking of atypical femoral fractures, which are often linked to osteoporosis and bisphosphonate therapy. It ensures that patients receive the necessary follow-up care and management for their bone health.
